Monkeypox Clinical Trials in Kinshasa
4 recruitingKinshasa, Democratic Republic of the Congo
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa
Mpox (Monkeypox)
BioNTech SE310 enrolled6 locationsNCT07379580
Recruiting
Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
Mpox (Monkeypox)
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia550 enrolled1 locationNCT07267390
Recruiting
Phase 2
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
Mpox (Monkeypox)
Institute of Tropical Medicine, Belgium600 enrolled1 locationNCT06839989
Recruiting
Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
Monkeypox (Mpox)
Institute of Tropical Medicine, Belgium1,000 enrolled2 locationsNCT06840860